DOI · e01.org

BTF3 Silencing Inhibits the Proliferation of Osteosarcoma Cells

Qi Liu, Lin Jiang, Wanchun Wang, Tao Jiang · Journal of Cancer · 2019

  • DOI 10.7150/jca.28476
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2019

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2019

Abstract

Osteosarcoma (OS) is one of the bone malignancy cancers with poor prognosis in the early stages worldwide.Basic transcription factor 3 (BTF3) is associated with the development of several types of cancer.The present study aimed to evaluate the role of BTF3 in OS.Silencing of BTF3 was achieved by using stable lentivirus transfection of siRNA targeting BTF3 in the human OS cell line Saos-2.Cell viability and colony-forming ability were measured using methyl-thaizolyl-tetrazolium (MTT) and colony formation assays, respectively.Propidium iodide staining and flow cytometry was used to detect the progression of the cell cycle.To evaluate the possible intracellular signaling molecules involved, a PathScan Intracellular Signaling Array Kit was utilized.Lentivirus-BTF3-shRNA (LV-BTF3-shRNA) suppressed expression of BTF3 in Saos-2 cells (inhibition ratio: 89.8%), which significantly inhibited cell proliferation (48.5%), colony formation and enhanced apoptosis to 48.2% compared to 4.5% with lentivirus control shRNA (N-shRNA).Additionally, BTF3 silencing enhanced the percentage of Saos-2 cells in S and G 2 /M phases, but significantly reduced cells in the G0/M phase (all P < 0.01).The proteins activated by BTF3 included STAT3, S6 ribosomal protein, HSP27 and SAPK/JNK2, all of which were inhibited by BTF3 silencing, whereas SAPK/JNK1 was upregulated by BTF3 silencing.In the present study, we explored the crucial role of BTF3 in promoting OS cell proliferation as well as laying the foundations for further research to investigate the clinical potential of lentivirus-mediated delivery of BTF3 interruption therapy for the treatment of OS.

Open the resolved locator · 10.7150/jca.28476

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:03 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v10p1855.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.